Enhanced vulnerability to oxidative stress by α-synuclein mutations and C-terminal truncation

Neuroscience

Volumn 97, Issue 2, 2000, Pages 279-284

  Kanda, S ^a   Bishop, J F ^a   Eglitis, M A ^a   Yang, Y ^a   Mouradian, M M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cell death; Neuron; Oxidative stress; Parkinson's disease; Synuclein

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA SYNUCLEIN; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MUTATION; NERVE CELL; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL;

1-METHYL-4-PHENYLPYRIDINIUM; ALPHA-SYNUCLEIN; AMINO ACID SUBSTITUTION; BRAIN; CELL SURVIVAL; HUMANS; HYDROGEN PEROXIDE; MUTAGENESIS, SITE-DIRECTED; NERVE TISSUE PROTEINS; NEUROBLASTOMA; OXIDATIVE STRESS; PHOSPHOPROTEINS; RECOMBINANT PROTEINS; SEQUENCE DELETION; SYNUCLEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034008852     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00077-4     Document Type: Article

References (28)

1. Alam Z.I., Daniel S.E., Lees A.J., Marsden D.C., Jenner P., Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69:1997;1326-1329.
2. Alam Z.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69:1997;1196-1203.
3. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., Iwatsubo T. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Path. 152:1998;879-884.
4. Bennett M.C., Bishop J.F., Leng Y., Chock P.B., Chase T.N., Mouradian M.M. Degradation of α-synuclein by proteasome. J. biol. Chem. 274:1999;33,855-33,858.
5. Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38:1978;3751-3757.
6. Conway K.A., Harper J.D., Lansbury P.T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4:1998;1318-1320.
7. Crowther R.A., Jakes R., Spillantini M.G., Goedert M. Synthetic filaments assembled from C-terminally truncated α-synuclein. Fedn. Eur. biochem. Socs Lett. 436:1998;309-312.
8. Cummings C.J., Reinstein E., Sun Y., Antalffy B., Jiang Y., Ciechanover A., Orr H.T., Beaudet A.L., Zoghbi H.Y. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron. 24:1999;879-892.
9. Dickson D.W., Liu W., Hardy J., Farrer M., Mehta N., Uitti R., Mark M., Zimmerman T., Golbe L., Sage J., Sima A., D'Amato C., Albin R., Gilman S., Yen S.H. Widespread alterations of α-synuclein in multiple system atrophy. Am. J. Path. 155:1999;1241-1251.
10. El-Agnaf O.M., Jakes R., Curran M.D., Middleton D., Ingenito R., Bianchi E., Pessi A., Neill D., Wallace A. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. Fedn Eur. biochem. Socs Lett. 440:1998;71-75.
11. El-Agnaf O.M., Jakes R., Curran M.D., Wallace A. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α-synuclein protein implicated in Parkinson's disease. Fedn Eur. biochem. Socs Lett. 440:1998;67-70.
12. Giasson B.I., Uryu K., Trojanowski J.Q., Lee V.M. Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. biol. Chem. 274:1999;7619-7622.
13. Irizarry M.C., Growdon W., Gomez-Isla T., Newell K., George J.M., Clayton D.F., Hyman B.T. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J. Neuropath. exp. Neurol. 57:1998;334-337.
14. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov. Disord. 1:1998;24-34.
15. Klement I.A., Skinner P.J., Kaytor M.D., Yi H., Hersch S.M., Clark H.B., Zoghbi H.Y., Orr H.T. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 95:1998;41-53.
16. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schol L., Riess O. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108.
17. Lippa C.F., Fujiwara H., Mann D.M., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., St George-Hyslop P., Ghetti B., Nochlin D., Bird T.D., Cairns N.J., Lee V.M., Iwatsubo T., Trojanowski J.Q. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Path. 153:1998;1365-1370.
18. McLachlin J.R., Mittereder N., Daucher M.B., Kadan M., Eglitis M.A. Factors affecting retroviral vector function and structural integrity. Virology. 195:1993;1-5.
19. Mezey E., Dehejia A., Harta G., Papp M.I., Polymeropoulos M.H., Brownstein M.J. Alpha synuclein in neurodegenerative disorders: murderer or accomplice? Nat. Med. 4:1998;755-757.
20. Narhi L., Wood S.J., Steavenson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Martin F., Sitney K., Denis P., Louis J.C., Wypych J., Biere A.L., Citron M. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. biol. Chem. 274:1999;9843-9846.
21. Ostrerova N., Petrucelli L., Farrer M., Mehta N., Choi P., Hardy J., Wolozin B. α-Synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19:1999;5782-5791.
22. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
23. Saudou F., Finkbeiner S., Devys D., Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66.
24. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. natn. Acad. Sci. U.S.A. 95:1998;6469-6473.
25. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., Masliah E. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am. J. Path. 152:1998;367-372.
26. Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 90:1993;11,282-11,286.
27. Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M., Takahashi H. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci. Lett. 239:1997;45-48.
28. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. natn. Acad. Sci. U.S.A. 93:1996;2696-2701.